Theravance Biopharma (TBPH) EPS (Basic) (2013 - 2026)
Theravance Biopharma (TBPH) posted quarterly EPS (Basic) of -$0.1 for Q1 2026, up 64.52% year-over-year from -$0.06 in Q1 2025, and down 117.02% quarter-over-quarter from $0.57 in Q4 2025.
Powered by 
Analysis
Theravance Biopharma (TBPH) EPS (Basic) (2013 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has reported EPS (Basic) for 14 consecutive years, with -$0.1 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 64.52% year-over-year to -$0.1; the TTM figure through Mar 2026 stood at $1.6 (up 236.47% YoY), while the FY2025 annual figure was $1.39, up 220.6% from the prior year.
- EPS (Basic) declined to -$0.1 in Q1 2026 per TBPH's latest filing, from $0.57 in the prior quarter.
- Across five years, EPS (Basic) topped out at $12.28 in Q3 2022 and bottomed at -$0.34 in Q1 2023.
- Historically, EPS (Basic) has averaged $0.71 across 5 years, with a median of -$0.1 in 2026.
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 4284.34% — and 2023, when it sank 281.22%.
- Theravance Biopharma's EPS (Basic) stood at $0.05 in 2022, then tumbled by 281.22% to -$0.1 in 2023, then slumped by 231.49% to -$0.32 in 2024, then surged by 279.11% to $0.57 in 2025, then plunged by 117.02% to -$0.1 in 2026.
- Business Quant data shows TBPH's EPS (Basic) at -$0.1 in Q1 2026, $0.57 in Q4 2025, and $0.07 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Theravance Biopharma | 882.21 Mn | 494.56 Mn | - | -0.11 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | 0.98 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 1.09 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | -0.51 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.34 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.15 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.34 |
| Dec 31, 2022 | 2.29 |
| Sep 30, 2022 | 12.07 |
| Jun 30, 2022 | -0.06 |
| Mar 31, 2022 | -0.33 |
| Dec 31, 2021 | -0.46 |
| Sep 30, 2021 | -0.48 |